Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Care Publish Ahead of Print published online ahead of print June 15, 2007
DOI: 10.2337/dc07-0525

This Article
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
dc07-0525v1
30/9/2349    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Colussi, G.
Right arrow Articles by Sechi, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Colussi, G.
Right arrow Articles by Sechi, L. A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Insulin Resistance and Hyperinsulinemia are Related to Plasma Aldosterone Levels in Hypertensive Patients

GianLuca Colussi, M.D.1, Cristiana Catena, M.D., Ph.D.1, Roberta Lapenna, M.D.1, Elisa Nadalini, M.D.1, Alessandra Chiuch, M.D.1 and Leonardo A. Sechi, M.D.1

1Division of Internal Medicine, Hypertension and Diabetes Unit, Department of Experimental and Clinical Pathology and Medicine, University of Udine, 33100 Udine, Italy

sechi{at}uniud.it

ABSTRACT

Objective.: Association between aldosterone and insulin resistance has been demonstrated in obesity, primary aldosteronism, and in blacks with the metabolic syndrome. The aim of this study was to evaluate the relationship of plasma aldosterone with insulin sensitivity in white subjects.

Research Design and Methods.: In 356 patients with essential hypertension and 102 normotensive controls of comparable age and BMI, we measured, after discontinuation of treatment, plasma active renin, aldosterone, cortisol, glucose, insulin, and C-peptide levels, and calculated markers of insulin sensitivity. Direct assessment of insulin sensitivity was obtained in a subset of 64 hypertensive patients by a hyperinsulinemic clamp.

Results.: Hypertensive patients had significantly greater fasting plasma insulin and C-peptide concentrations, and HOMA index than normotensive controls. Positive association with increasing plasma aldosterone concentrations was demonstrated for plasma glucose, insulin, C-peptide, and HOMA. Assessment of insulin sensitivity by the clamp showed significant decrease of the metabolic clearance rate (MCR) of glucose with increasing aldosterone levels. Significant correlations were found between plasma aldosterone and plasma insulin, and C-peptide levels, HOMA, and glucose MCR. Blood pressure and plasma potassium, plasma cortisol, and renin levels, but not BMI, were also directly correlated with plasma aldosterone. Multiple regression analysis showed that HOMA, together with plasma potassium, cortisol, and renin levels, was independently correlated with plasma aldosterone.

Conclusions.: This study demonstrates a direct relationship between aldosterone, insulin resistance, and hyperinsulinemia in white subjects. In patients with hypertension this relationship might contribute to maintenance of high blood pressure and increase cardiovascular risk.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
HypertensionHome page
M. L. Muiesan, M. Salvetti, A. Paini, C. Agabiti-Rosei, C. Monteduro, G. Galbassini, E. Belotti, C. Aggiusti, D. Rizzoni, M. Castellano, et al.
Inappropriate Left Ventricular Mass in Patients With Primary Aldosteronism
Hypertension, September 1, 2008; 52(3): 529 - 534.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. W. Krug and M. Ehrhart-Bornstein
Aldosterone and Metabolic Syndrome: Is Increased Aldosterone in Metabolic Syndrome Patients an Additional Risk Factor?
Hypertension, May 1, 2008; 51(5): 1252 - 1258.
[Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. M. C. Connell, S. M. MacKenzie, E. M. Freel, R. Fraser, and E. Davies
A Lifetime of Aldosterone Excess: Long-Term Consequences of Altered Regulation of Aldosterone Production for Cardiovascular Function
Endocr. Rev., April 1, 2008; 29(2): 133 - 154.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. Perciaccante, A. Fiorentini, R. Valente, A. Di Stefano, and L. Tubani
Insulin Resistance and Hyperinsulinemia Are Related to Plasma Aldosterone Levels in Hypertensive Patients: Response to Colussi et al.
Diabetes Care, October 1, 2007; 30(10): e106 - e106.
[Full Text] [PDF]


Home page
Diabetes CareHome page
G. Colussi, C. Catena, R. Lapenna, E. Nadalini, A. Chiuch, and L. A. Sechi
Insulin Resistance and Hyperinsulinemia Are Related to Plasma Aldosterone Levels in Hypertensive Patients: Response to Perciaccante et al.
Diabetes Care, October 1, 2007; 30(10): e107 - e107.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.